Coenzyme Q10 and Dentoalveolar Cyst

NCT05873673 · tracked via the Priya Life Science Egypt tracker

Sponsor

Fayoum University

Phase

Phase 2

Started

2023-06-11

Last updated

2025-03-03

Condition(s) studied

Cyst, Jaw

Investigational drug(s) / intervention(s)

Coenzyme Q10 →control group

Coenzyme Q10: cystic jaw defect filled with coenzyme Q10 gel

control group: cystic jaw defect filled with placebo gel

Study summary

10 patients in each group will undergo cyst removal under local anesthesia. After cyst removal, the cystic cavity will be filled with placebo gel in the control group or coenzyme gel in the coenzyme group.

Bone density and volume will be assessed by cone beam CT immediately postoperative and 6months later for all patients

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Adult patients with critical-size jaw cysts * Medically stable * No cystic lesion recurrence Exclusion Criteria: * Cystic lesion recurrence * Medical problem

Primary outcome measure(s)

bone density — 6 months
measure the bone density of new bone in the cystic cavity at 6 months by cone beam CT

Trial sites (1)

Facility	City	Region	Status
Fayoum University	Al Fayyum	Egypt

More Fayoum University trials in Egypt

Efficacy of Ultrasound-guided Greater Auricular Nerve Block in Preventing Postoperative Emergence Agitation in Pediatric Patients Undergoing Microscopic Middle Ear Surgery. Recruiting

Impact of a High-Protein Diet on Clinical Outcomes in Mechanically Ventilated Patients With Severe Pneumonia Active, not recruiting

Vertical Ramus Osteotomy With Iliac Graft Versus Sagittal Split Osteotomy Recruiting

Does Addition of Medial Pterygoid Muscle Injection Improve the Outcome of Botulinum Toxin Therapy for Masticatory Myofascial Pain Syndrome? Starting soon

Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05873673 on ClinicalTrials.gov ↗ ← All trials in Egypt